840
Views
52
CrossRef citations to date
0
Altmetric
Original Article

Safety and pharmacokinetics of subcutaneous ceftriaxone administered with or without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone administration in adult volunteers

, , &
Pages 279-288 | Accepted 22 Oct 2009, Published online: 01 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Stephen P. Knowles, Marie A. Printz, David W. Kang, Michael J. LaBarre & Renee P. Tannenbaum. (2021) Safety of recombinant human hyaluronidase PH20 for subcutaneous drug delivery. Expert Opinion on Drug Delivery 18:11, pages 1673-1685.
Read now
Christina Theodore-Oklota, Louise Humphrey, Christof Wiesner, Gabriel Schnetzler, Stacie Hudgens & Alicyn Campbell. (2016) Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab. Patient Preference and Adherence 10, pages 1767-1776.
Read now
Emmanuel Forestier, Thibaut Fraisse, Claire Roubaud-Baudron, Christine Selton-Suty & Leonardo Pagani. (2016) Managing infective endocarditis in the elderly: new issues for an old disease. Clinical Interventions in Aging 11, pages 1199-1206.
Read now
Jing-fen Jin, Ling-ling Zhu, Meng Chen, Hui-min Xu, Hua-fen Wang, Xiu-qin Feng, Xiu-ping Zhu & Quan Zhou. (2015) The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection. Patient Preference and Adherence 9, pages 923-942.
Read now
Salima Hamizi, Gilles Freyer, Naoual Bakrin, Emilie Henin, Amina Mohtaram, Olivia Le Saux & Claire Falandry. (2013) Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer. OncoTargets and Therapy 6, pages 89-94.
Read now
Stephen Jolles. (2013) Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency. ImmunoTargets and Therapy 2, pages 125-133.
Read now
Marcelo Sandoval, Patricia Coleman, Rahim Govani, Saima Siddiqui & Knox H. Todd. (2013) Pilot Study of Human Recombinant Hyaluronidase–Enhanced Subcutaneous Hydration and Opioid Administration for Sickle Cell Disease Acute Pain Episodes. Journal of Pain & Palliative Care Pharmacotherapy 27:1, pages 10-18.
Read now

Articles from other publishers (45)

M. Burbank, F. Gautier, N. Hewitt, A. Detroyer, L. Guillet-Revol, L. Carron, T. Wildemann, T. Bringel, A. Riu, A. Noel-Voisin, N. De Croze, M. Léonard & G. Ouédraogo. (2023) Advancing the use of new approach methodologies for assessing teratogenicity: Building a tiered approach. Reproductive Toxicology 120, pages 108454.
Crossref
Fawaz Alasmari, Mohammed S. Alasmari, Hussa Mubarak Muwainea, Hatun A. Alomar, Abdullah F. Alasmari, Sary Alsanea, Aws Alshamsan, Muhammad F. Rasool & Faleh Alqahtani. (2023) Physiologically-based pharmacokinetic modeling for single and multiple dosing regimens of ceftriaxone in healthy and chronic kidney disease populations: a tool for model-informed precision dosing. Frontiers in Pharmacology 14.
Crossref
Marie Jumpertz, Romain Guilhaumou, Matthieu Million, Philippe Parola, Jean-Christophe Lagier, Philippe Brouqui & Nadim Cassir. (2023) Subcutaneously administered antibiotics: a review. Journal of Antimicrobial Chemotherapy 78:1, pages 1-7.
Crossref
. 2022. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin 775 798 .
Martin Sindelar, Jana Jilkova, Lukas Kubala, Vladimir Velebny & Kristyna Turkova. (2021) Hyaluronidases and hyaluronate lyases: From humans to bacteriophages. Colloids and Surfaces B: Biointerfaces 208, pages 112095.
Crossref
Michael J. Dolton, Aaron Chesterman, Anita Moein, Kaycee M. Sink, Ariel Waitz, Kathleen Blondeau, Geoffrey A. Kerchner, Nan Hu, Logan Brooks, Monica K. Wetzel‐Smith, Amanda Roden, Ajay Deshmukh, Kun Peng, Montserrat Carrasco‐Triguero, Jill Smith, Susanne Ostrowitzki & Angelica Quartino. (2021) Safety, Tolerability, and Pharmacokinetics of High‐Volume Subcutaneous Crenezumab, With and Without Recombinant Human Hyaluronidase in Healthy Volunteers. Clinical Pharmacology & Therapeutics 110:5, pages 1337-1348.
Crossref
Constanze Rémi, Stefanie Büsel, Mara Volk, Matthias Anzböck, Carolin Wolf & Ruth Leskowschek. (2021) Subkutane Arzneimittelanwendung in der Palliativmedizin. Zeitschrift für Palliativmedizin 22:05, pages 255-264.
Crossref
Jessica A. Cowell, Marie A. Printz & Curtis B. Thompson. (2021) Recombinant human hyaluronidase PH20-mediated dermal spreading activity in mice is not altered by steroids, antihistamines, or salicylic acid. Drug Metabolism and Drug Interactions 36:2, pages 155-163.
Crossref
Virgilio Hernández-Ruiz, Emmanuel Forestier, Gaëtan Gavazzi, Tristan Ferry, Nicolas Grégoire, Dominique Breilh, Marc Paccalin, Sylvain Goutelle & Claire Roubaud-Baudron. (2021) Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When. Journal of the American Medical Directors Association 22:1, pages 50-55.e6.
Crossref
Tristan Ferry, Thomas P. Lodise, Jason C. Gallagher, Emmanuel Forestier, Sylvain Goutelle, Vincent H. Tam, John F. MohrIIIIII & Claire Roubaud-Baudron. (2020) Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections. Frontiers in Medicine 7.
Crossref
Francesca Angelotti, Riccardo Capecchi, Daiana Giannini, Ornella Mazzarella, Valeria Rocchi & Paola Migliorini. (2020) Long-term efficacy, safety, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin (Ig) (fSCIG; HyQvia(®)) in immunodeficiency diseases: real-life data from a monocentric experience. Clinical and Experimental Medicine 20:3, pages 387-392.
Crossref
E. Colin, A. Baldolli, R. Verdon & G. Saint-Lorant. (2020) Subcutaneously administered antibiotics. Médecine et Maladies Infectieuses 50:3, pages 231-242.
Crossref
Richard L. Wasserman. (2020) Clinical Practice Experience with HyQvia in Adults Using Alternative Dosing Regimens and Pediatric Patients: A Retrospective Study. Advances in Therapy 37:4, pages 1536-1549.
Crossref
John P. Koulakis, Joshua Rouch, Nhan Huynh, Holden H. Wu, James C. Y. Dunn & Seth Putterman. (2020) Tumescent Injections in Subcutaneous Pig Tissue Disperse Fluids Volumetrically and Maintain Elevated Local Concentrations of Additives for Several Hours, Suggesting a Treatment for Drug Resistant Wounds. Pharmaceutical Research 37:3.
Crossref
Claire Roubaud Baudron, Rachel Legeron, Julien Ollivier, Fabrice Bonnet, Carine Greib, Florent Guerville, Charles Cazanave, David Kobeh, Véronique Cressot, Nicolas Moneger, Marie-Neige Videau, Elise Thiel, Carine Foucaud, Aurélie Lafargue, Albane de Thezy, Jessica Durrieu, Isabelle Bourdel Marchasson, Geneviève Pinganaud & Dominique Breilh. (2019) Is the subcutaneous route an alternative for administering ertapenem to older patients? PHACINERTA study. Journal of Antimicrobial Chemotherapy 74:12, pages 3546-3554.
Crossref
Cécile Pouderoux, Agathe Becker, Sylvain Goutelle, Sébastien Lustig, Claire Triffault-Fillit, Fatiha Daoud, Michel Henry Fessy, Sabine Cohen, Frédéric Laurent, Christian Chidiac, Florent Valour, Tristan Ferry, Tristan Ferry, Florent Valour, Thomas Perpoint, Patrick Miailhes, Florence Ader, Agathe Becker, Sandrine Roux, Claire Triffault-Fillit, Anne Conrad, Marielle Perry, Cécile Pouderoux, Fatiha Daoud, Johanna Lippman, Evelyne Braun, Christian Chidiac, Sébastien Lustig, Elvire Servien Cécile Batailler, Romain Gaillard, Stanislas Gunst, Julien Roger, Charles Fiquet, Michel-Henry Fessy, Anthony Viste, Philippe Chaudier, Jean-Luc Besse, Lucie Louboutin, Gaël Gaudin, Tanguy Ledru, Andrien Van Haecke, Quentin Ode, Marcelle Mercier, Florie Alech-Tournier, Sébastien Martres, Franck Trouillet, Cédric Barrey, Emmanuel Jouanneau, Timothée Jacquesson, Brice Gerenton, Ali Mojallal, Fabien Boucher, Hristo Shipkov, Philippe Céruse, Carine Fuchsmann, Arnaud Gleizal, Frédéric Aubrun, Mikhail Dziadzko, Caroline Macabéo, Frederic Laurent, Laetitia Beraut, Céline Dupieux, Camille Kolenda, Jérôme Josse, Claude-Alexandre Gustave, Fabien Craighero, Loic Boussel, Jean-Baptiste Pialat, Isabelle Morelec, Michel Tod, Marie-Claude Gagnieu, Sylvain Goutelle & Eugénie Mabrut. (2019) Subcutaneous suppressive antibiotic therapy for bone and joint infections: safety and outcome in a cohort of 10 patients. Journal of Antimicrobial Chemotherapy 74:7, pages 2060-2064.
Crossref
Gregor Cornelius Weber, Bettina Alexandra Buhren, Holger Schrumpf, Johannes Wohlrab & Peter Arne Gerber. 2019. Therapeutic Enzymes: Function and Clinical Implications. Therapeutic Enzymes: Function and Clinical Implications 255 277 .
Oscar Duems Noriega & Sulema N. Yarlequé León. (2018) Antibiotics by Subcutaneous Route: A Safe and Efficient Alternative. Journal of the American Medical Directors Association 19:6, pages 553-554.
Crossref
Massimo Radin, Dario Roccatello, Simone Baldovino & Savino Sciascia. (2018) Facilitated subcutaneous immunoglobulin treatment in pemphigus vulgaris. BMJ Case Reports, pages bcr-2017-223302.
Crossref
. 2018. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin 697 719 .
Tina Kauss, Mathieu Marchivie, Thida Phoeung, Alexandra Gaubert, Amélie Désiré, Giovanni Tonelli, Chantal Boyer, Marie-Hélène Langlois, Anthony Cartwright, Melba Gomes, Nicholas White & Karen Gaudin. (2017) Preformulation studies of ceftriaxone for pediatric non-parenteral administration as an alternative to existing injectable formulations. European Journal of Pharmaceutical Sciences 104, pages 382-392.
Crossref
Richard L Wasserman, Isaac Melamed, Lisa Kobrynski, Jennifer Puck, Sudhir Gupta, Jennifer Doralt, Marlies Sharkhawy, Werner Engl, Heinz Leibl, David Gelmont & Leman Yel. (2016) Recombinant human hyaluronidase facilitated subcutaneous immunoglobulin treatment in pediatric patients with primary immunodeficiencies: long-term efficacy, safety and tolerability. Immunotherapy 8:10, pages 1175-1186.
Crossref
Shan Liu, Bo Xie, Wei Wei, Mizhou Hui & Zhiguo Su. (2016) Design and preparation of chimeric hyaluronidase as a chaperone for the subcutaneous administration of biopharmaceuticals. Biochemical Engineering Journal 112, pages 32-41.
Crossref
Richard L. Wasserman, Isaac Melamed, Mark R. Stein, Werner Engl, Marlies Sharkhawy, Heinz Leibl, Jennifer Puck, Arye Rubinstein, Lisa Kobrynski, Sudhir Gupta, Andrew J. Grant, Anoshie Ratnayake, Wendell G. Richmond, Joseph Church, Leman Yel & David Gelmont. (2016) Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency. Journal of Clinical Immunology 36:6, pages 571-582.
Crossref
Sarit Assouline, Valeria Buccheri, Alain Delmer, Gianluca Gaidano, Marek Trneny, Natalia Berthillon, Michael Brewster, Olivier Catalani, Sai Li, Christine McIntyre, Pakeeza Sayyed & Xavier Badoux. (2016) Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial. The Lancet Haematology 3:3, pages e128-e138.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 864 867 .
Sarit Assouline, Valeria Buccheri, Alain Delmer, Gianluca Gaidano, Christine McIntyre, Michael Brewster, Olivier Catalani, Florence Hourcade-Potelleret, Pakeeza Sayyed & Xavier Badoux. (2015) Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia. British Journal of Clinical Pharmacology 80:5, pages 1001-1009.
Crossref
Sanna Rosengren, Samuel S. Dychter, Marie A. Printz, Lei Huang, Richard I. Schiff, Hans-Peter Schwarz, John K. McVey, Fred H. Drake, Dan C. Maneval, Don A. Kennard, Gregory I. Frost, Barry J. Sugarman & Douglas B. Muchmore. (2015) Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration. The AAPS Journal 17:5, pages 1144-1156.
Crossref
Annette O. Arthur. (2015) Innovations in Subcutaneous Infusions. Journal of Infusion Nursing 38:3, pages 179-187.
Crossref
Oscar Duems-Noriega & Sergio Ariño-Blasco. (2015) Subcutaneous fluid and drug delivery: safe, efficient and inexpensive. Reviews in Clinical Gerontology 25:2, pages 117-146.
Crossref
E. Forestier, M. Paccalin, C. Roubaud-Baudron, T. Fraisse, G. Gavazzi & J. Gaillat. (2015) Subcutaneously administered antibiotics: a national survey of current practice from the French Infectious Diseases (SPILF) and Geriatric Medicine (SFGG) society networks. Clinical Microbiology and Infection 21:4, pages 370.e1-370.e3.
Crossref
Susan Hofman, Mathieu S Bolhuis, Remco A Koster, Onno W Akkerman, Sander van Assen, Christophe Stove & Jan-Willem C Alffenaar. (2015) Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples. Bioanalysis 7:4, pages 481-495.
Crossref
Antonio SalarIrit AviviBeate BittnerReda BouabdallahMike BrewsterOlivier CatalaniGeorge FollowsAndrew HaynesFlorence Hourcade-PotelleretAndrea JanikovaJean-François LaroucheChristine McIntyreMichael PedersenJuliana PereiraPakeeza SayyedOfer ShpilbergGayane Tumyan. (2014) Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study. Journal of Clinical Oncology 32:17, pages 1782-1791.
Crossref
D. Gauthier, S. Schambach, J. Crouzet, S. Sirvain & T. Fraisse. (2014) Subcutaneous and intravenous ceftriaxone administration in patients more than 75 years of age. Médecine et Maladies Infectieuses 44:6, pages 275-280.
Crossref
Richard L Wasserman. (2014) Overview of recombinant human hyaluronidase-facilitated subcutaneous infusion of IgG in primary immunodeficiencies. Immunotherapy 6:5, pages 553-567.
Crossref
Johannes Wohlrab, David Wohlrab, Lukas Wohlrab, Christiane Wohlrab & Angelika Wohlrab. (2014) Use of Hyaluronidase for Pharmacokinetic Increase in Bioavailability of Intracutaneously Applied Substances. Skin Pharmacology and Physiology 27:5, pages 276-282.
Crossref
N.H. Choulis. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 899 924 .
Vincent Launay-Vacher. (2013) An appraisal of subcutaneous trastuzumab: a new formulation meeting clinical needs. Cancer Chemotherapy and Pharmacology 72:6, pages 1361-1367.
Crossref
O Shpilberg & C Jackisch. (2013) Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase. British Journal of Cancer 109:6, pages 1556-1561.
Crossref
Philip R. Spandorfer, Sharon E. Mace, Pamela J. Okada, Harold K. Simon, Coburn H. Allen, David M. Spiro, Keith Friend, George Harb & Francois Lebel. (2012) A Randomized Clinical Trial of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Versus Intravenous Rehydration in Mild to Moderately Dehydrated Children in the Emergency Department. Clinical Therapeutics 34:11, pages 2232-2245.
Crossref
Richard L. Wasserman, Isaac Melamed, Mark R. Stein, Sudhir Gupta, Jennifer Puck, Werner Engl, Heinz Leibl, Barbara McCoy, Victoria G. Empson, David Gelmont & Richard I. Schiff. (2012) Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency. Journal of Allergy and Clinical Immunology 130:4, pages 951-957.e11.
Crossref
Eliete Farias Azevedo, Leandro Augusto Barbosa & Silvia Helena De Bortoli Cassiani. (2012) Administração de antibióticos por via subcutânea: uma revisão integrativa da literatura. Acta Paulista de Enfermagem 25:5, pages 817-822.
Crossref
Sandra Connolly, Helen Korzemba, George Harb, Francois Lebel & Christine Syltevik. (2011) Techniques for Hyaluronidase-Facilitated Subcutaneous Fluid Administration With Recombinant Human Hyaluronidase. Journal of Infusion Nursing 34:5, pages 300-307.
Crossref
Laura L. Kuensting. (2011) Subcutaneous Infusion of Fluid in Children. Journal of Emergency Nursing 37:4, pages 346-349.
Crossref
Philip R. Spandorfer. (2011) Subcutaneous Rehydration. Pediatric Emergency Care 27:3, pages 230-236.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.